Fact based stock research
Bio-Rad Laboratories (NYSE:BIO)

US0905722072

Bio-Rad Laboratories stock research in summary

Bio-Rad Laboratories shares have a market-typical stock price level. They are safely financed, show above average growth and are good value. We recommend evaluating whether the future of the company Bio-Rad Laboratories is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.

Latest Obermatt Ranks


Value Rank	55
Growth Rank	57
Safety Rank	76
Combined Rank	61

Country	USA
Industry	Life Sciences Tools & Services
Index	S&P MIDCAP
Size class	Large

July 31, 2020. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist

Filter Similar Stocks

Similar Top 10

Google: Bio-Rad Laboratories

News	Videos
Wikipedia about Bio-Rad Laboratories	Management
Employee Satisfaction	Customer Satisfaction

Research History: Bio-Rad Laboratories

RESEARCH HISTORY	2017	2018	2019	2020
VALUE
VALUE	35	71	58	55
GROWTH
GROWTH	54	38	53	57
SAFETY
SAFETY	42	94	94	76
COMBINED
COMBINED	50	88	82	61

Last update of Combined Rank: 31-Jul-2020. Financial reporting date used for calculating ranks: 31-Mar-2020. Stock research history is based on the Obermatt Method. The higher the rank, the better Bio-Rad Laboratories is in the corresponding investment strategy.

Value Metrics in Detail

VALUE METRICS	2017	2018	2019	2020
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)	64	59	42	40
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)	34	100	98	98
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)	61	62	56	56
DIVIDEND YIELD
DIVIDEND YIELD	1	1	1	1
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE	35	71	58	55

Last update of Value Rank: 31-Jul-2020. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Bio-Rad Laboratories; except for dividend yield where the rank is higher, the higher the yield.

Growth Metrics in Detail

GROWTH METRICS	2017	2018	2019	2020
REVENUE GROWTH
REVENUE GROWTH	36	13	25	22
PROFIT GROWTH
PROFIT GROWTH	55	33	47	67
STOCK RETURNS
STOCK RETURNS	80	86	69	62
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH	54	38	53	57

Last update of Growth Rank: 31-Mar-2020. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Bio-Rad Laboratories.

Safety Metrics in Detail

SAFETY METRICS	2017	2018	2019	2020
LEVERAGE
LEVERAGE	46	56	50	52
REFINANCING
REFINANCING	63	74	62	62
LIQUIDITY
LIQUIDITY	82	81	94	92
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY	42	94	94	76

Last update of Safety Rank: 24-Jul-2020. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Bio-Rad Laboratories and the more cash is available to service its debt.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Bio-Rad Laboratories from July 31, 2020.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.